About us

Technology based innovative life-science company committed to pursuing for
healthier and cleaner world

News and Notice
News and Notice
[Ministry of Strategy and Finance] “BioActs”: The myth of developing medical diagnostic dyes ...
Writer : BioActs Date : 2018-12-11
File : 181211.jpg

 

[Ministry of Strategy and Finance] 2018.12.11

Innovative Growth Portal Excellent Company Example “BioActs”: The myth of developing medical diagnostic dyes to compete with global companies

 

The production of biomaterials such as animal fiber dyes has a high market value and used in the various medical fields such as diagnosis, treatment, surgery and pharmaceuticals in order to observe many characteristics of cells, organ, etc. Major biotech research institutes, universities and related companies in overseas has been invested huge amount of fund and researched long period in order to gain market share. BioActs, which has been recognized worldwide by offering a product based on state of art technology, is Korean company performing business and developing products to contribute and provide better health and life to mankind.

 

http://www.moef.go.kr/pa/archiveExclncEntrprsCaseList.do  

BEFORE
AFTER